According to TipRanks.com, Mehta is a 5-star analyst with an average return of 14.0% and a 65.1% success rate. Mehta covers the Utilities sector, focusing on stocks such as Southwestern Energy, Canadian Natural, and Antero Resources.
Currently, the analyst consensus on Hess is a Strong Buy with an average price target of $115.82, which is a 24.3% upside from current levels. In a report issued on March 11, Wells Fargo also maintained a Buy rating on the stock with a $133.00 price target.
The company has a one-year high of $102.99 and a one-year low of $61.93. Currently, Hess has an average volume of 2.83M.
Based on the recent corporate insider activity of 63 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of HES in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Hess Corp is an exploration and production company, which engages in exploration, development, production, transportation, purchase & sale of crude oil, natural gas liquids and natural gas with production operations. It operates through the following segments: Exploration and Production and Midstream. The Exploration and Production segment explores for, develops, produces, purchases and sells crude oil, natural gas liquids and natural gas. The Midstream segment provides fee-based services including crude oil and natural gas gathering, processing of natural gas and the fractionation of natural gas liquids, transportation of crude oil by rail car, terminaling and loading crude oil and natural gas liquids, and the storage and terminaling of propane, primarily in the Bakken shale play of North Dakota. The company was founded by Leon Hess in 1920 and is headquartered in New York, NY.
Read More on HES:
- These 2 Artificial Intelligence Stocks Are Set for Strong Growth, Says Truist
- BTIG Thinks Viewray’s Stock is Going to Recover
- Wells Fargo Keeps Their Buy Rating on Arthur J Gallagher & Co (AJG)
- JMP Securities Keeps Their Buy Rating on Adicet Bio (ACET)
- Mizuho Securities Thinks Satsuma Pharmaceuticals’ Stock is Going to Recover